Share-based Payments

12 Months Ended

Dec. 31, 2023

24.	Share-based Payments

(1)

Details of share-based payments granted by the Controlling to executives and employees, including the CEO, by the resolution of the Board of Directors for the years ended December 31, 2022 and 2023, are as follows:


		2022
(in share)		16th grant
Grant date		June 9, 2022
Grantee		CEO, internal directors, external directors, executives
Vesting conditions		Service condition: 1 year Non-market performance condition: achievement of performance
Fair value per option (in Korean won)		￦ 36,941
Total compensation costs (in Korean won)		￦ 9,442 million
Exercise date		July 17, 2023
Valuation method		Fair value method


		2023
(in share)		17th grant
Grant date		June 15, 2023, Oct 17, 2023
Grantee		CEO, internal directors, external directors, executives
Vesting conditions		Service condition: 1 year Non-market performance condition: achievement of performance
Fair value per option (in Korean won)		￦ 30,205
Total compensation costs (in Korean won)		￦ 7,262 million
Estimated exercise date (exercise date)		During 2024
Valuation method		Fair value method

(2)

Changes in the number of stock options and the weighted-average exercise price as at December 31, 2022 and 2023, are as follows:


(In share)	2022
	Beginning		Grant		Expired			Exercised 1			Ending		Number of shares exercisable
15th grant		284,209		—		(155,286	)		(128,923	)		—		—
16th grant		—		258,509		—			—			258,509		—

Total		284,209		258,509		(155,286	)		(128,923	)		258,509		—

(In share)	2023
	Beginning		Grant		Expired			Exercised 1			Ending		Number of shares exercisable
16th grant		258,509		—		(105,859	)		(131,690	)		20,960		—
17th grant		—		307,182		—			—			307,182		—

Total		258,509		307,182		(105,859	)		(131,690	)		328,142		—

The weighted average price of ordinary shares at the time of exercise, during the year ended December 31, 2023 is

￦

29,550 (2022:

￦

35,450).